# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-26-041483
Filing Date
2026-04-09
Accepted
2026-04-09 16:01:19
Documents
16
Period of Report
2026-05-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | pmn-20260520xdef14a.htm iXBRL | DEF 14A | 922337
2 | GRAPHIC | pmn-20260520xdef14a_a001.jpg | GRAPHIC | 27602
3 | GRAPHIC | pmn-20260520xdef14a_a008.jpg | GRAPHIC | 34812
4 | GRAPHIC | pmn-20260520xdef14a_bg001.jpg | GRAPHIC | 111765
5 | GRAPHIC | pmn-20260520xdef14a_bg002.jpg | GRAPHIC | 142937
| Complete submission text file | 0001104659-26-041483.txt |  | 2007903

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | EX-101.SCH | pmn-20260520.xsd | EX-101.SCH | 3045
7 | EX-101.LAB | pmn-20260520_lab.xml | EX-101.LAB | 3683
8 | EX-101.PRE | pmn-20260520_pre.xml | EX-101.PRE | 3118
19 | EXTRACTED XBRL INSTANCE DOCUMENT | pmn-20260520xdef14a_htm.xml | XML | 1592

Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41429 | Film No.: 26851521
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)